INSTITUTE FOR BIOMEDICAL SCIENCES (EIN 953468614) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1979

Legal Domicile

Principal Officer

PETER CHEN

Phone

8583421618

Tax Period

2024-01-01 to 2024-12-31

INSTITUTE FOR BIOMEDICAL SCIENCES, founded in 1979, is a small nonprofit in the Diseases & Disorders sector that reported $496K in total revenue in fiscal year 2024. Revenue decreased 15% compared to the prior year. The organization ran a surplus of $160K, a strong 32% operating margin.

Mission

RESEARCH AND DEVELOPMENT WITH GOAL OF DEFINING A MICROVASCULAR INDEX FOR NON-INVASIVE MONITORING OF VASCULAR HEALTH AND FOR EARLY DIAGNOSIS OF VASCULAR RELATED DISEASES. STEM CELL DIFFERENTIATION STUDY TO OPTIMIZE SELECTION OF SCAFFOLDS, CELL TYPES AND STIMULATION FOR TISSUE REGENERATION OF CARTILAGE FOR THE TREATMENT OF OSTEOARTHRITIS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $90,000

Program Service Revenue $0

Investment Income $80,251

Other Revenue $325,400

TOTAL REVENUE $495,651

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $330,640

Other Expenses $336,020

TOTAL EXPENSES $336,020

Year-over-Year Comparison

	2024	2023	Change
Revenue	$495,651	$584,224	-0.2%
Expenses	$336,020	$515,214	-0.3%
Net Income	$159,631	$69,010	+1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ANTHONY CHEUNG	BOARD	1.00	Director	$0	$0	$0
CLIFFORD COLWELL	BOARD	1.00	Director	$0	$0	$0
PETER CHEN	PRESIDENT	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$495,651	$336,020	$1,372,680	$159,631
2023	$584,224	$515,214	$1,212,870	$69,010
2022	$441,972	$363,697	$1,143,713	$78,275
2021	$758,329	$213,736	$1,062,120	$544,593
2020	$246,843	$181,917	$531,666	$64,926
2019	$209,070	$138,325	$462,912	$70,745
2018	$279,007	$236,738	$381,409	$42,269

INSTITUTE FOR BIOMEDICAL SCIENCES